Cost-effectiveness of extending the HPV vaccination to boys: a systematic review.
Renata LinertováCarmen Guirado-FuentesJavier Mar MedinaIñaki Imaz-IglesiaLeticia Rodríguez-RodríguezMontserrat Carmona-RodríguezPublished in: Journal of epidemiology and community health (2021)
The evidence of the cost-effectiveness of extending HPV vaccination to boys is scarce and ambiguous. Before the adoption of such a strategy, countries should carry out context-specific cost-effectiveness analyses, but the decision should also take into account other criteria, such as gender-related equality.